Facility Sharing in Life Sciences - Promoting innovation in NWE life science SMEs by enabling easy transnational access to research facilities

Closed

FASILIS will open up public and private research infrastructures in the field of human health (biotech. pharmaceutical and medical technology) to SMEs from other regions in NWE. The aim is to give SMEs access to a far wider range of research facilities than is currently available at a regional level. broadening the competence networks of both SMEs and research infrastructures and so contributing strongly to increasing regional innovation capacity in the field of human health. To achieve this. the project will create an innovative transnational facility sharing infrastructure that can be easily continued beyond the finalisation of the project. and will: • give SMEs a single contact point for information on and support for accessing facilities with relevant expertise in other regions • make SMEs fully aware on the available competences. expertise and facilities available in other regions and their potential added value. and actively stimulate SMEs in accessing these facilities • assure full and easy accessibility of regional facilities to SMEs from other regions under a set of pre-defined (common) access rules • stimulate the initiation of durable long-term transnational cooperation between SMEs and facilities through a transnational voucher scheme The project will achieve this with partners representing 6 leading regional human health clusters. including the Oxford cluster in South East England. Health Valley in the Eastern Netherlands. Medicon Valley in the Oresund region. the Noord-Brabant LifetecZONe cluster. Bioregion STERN around Stuttgart and the BioLiege cluster in Wallonia. Jointly these clusters contain over 1.700 high-tech SME and over 45 leading research facilities. Biologue. the only partner not from the NWE area. is included because of their unique hands-on experience in bringing together SME’s with public R&D facilities cooperation opportunities for cooperation with Medicon Value. the second-largest bioscience cluster in Europe.

Medium